Discover the most effective treatments for Wet AMD, including advanced Anti-VEGF injections like **Vabysmo**, offered by Prof. Dr. Suhail Sarwar, a leading retinal specialist in Lahore.
Book Your AMD Consultation**Age-Related Macular Degeneration (AMD)** is a common eye condition and a leading cause of vision loss among people aged 50 and older. It affects the macula, the central part of the retina responsible for sharp, detailed vision needed for tasks like reading, driving, and recognizing faces. AMD typically progresses slowly and painlessly, but can lead to significant central vision impairment.
There are two main types of AMD:
Timely diagnosis and appropriate treatment, especially for Wet AMD, are crucial to preserve vision. Prof. Dr. Suhail Sarwar is an expert in managing both types of AMD.
**Characteristics:** Gradual vision loss, drusen deposits, thinning macula.
**Treatment:** AREDS2 supplements to slow progression. No surgical cure.
**Characteristics:** Rapid vision loss, abnormal leaking blood vessels, fluid/blood under macula.
**Treatment:** Anti-VEGF injections (e.g., Vabysmo, Lucentis, Eylea) to stop leakage.
For **Wet AMD**, the primary and most effective treatment involves **Anti-VEGF (Anti-Vascular Endothelial Growth Factor) injections**. These medications are injected directly into the eye to block a protein (VEGF) that causes abnormal, leaky blood vessels to grow under the retina.
🔬
Triggers abnormal blood vessel growth in Wet AMD.
💉
Medication injected into the eye to block VEGF.
💧🚫
Reduces fluid and blood from abnormal vessels under the macula.
👁️✨
Helps stabilize or improve central vision.
These injections are performed by a retinal specialist like Prof. Dr. Suhail Sarwar in a sterile environment. The procedure is quick and generally well-tolerated.
For **Wet AMD**, Anti-VEGF injections are universally recognized as the **best treatment** and the **drug of choice**. They have revolutionized AMD care, preventing severe vision loss for millions.
🌟
Commonly used Anti-VEGF drugs include:
🆕
**Vabysmo (Faricimab)** is one of the latest advancements. It's unique because it targets two pathways (VEGF-A and Ang-2) that contribute to Wet AMD. This dual action can lead to:
Anti-VEGF injections have a high success rate in stabilizing vision for Wet AMD patients.
📈
The majority of patients (over 90%) maintain their vision, and a significant portion (around 30-40%) experience an improvement in visual acuity. The goal is to prevent further vision loss.
🗓️
Initially, a **loading phase** of 3 monthly injections is common. After that, the frequency varies:
The cost of macular degeneration injections in Pakistan can vary significantly. Factors influencing the cost include:
💊
Newer drugs like Vabysmo, Lucentis, and Eylea typically have a higher cost per injection compared to Avastin (which is used off-label).
🏥
Costs can differ between private clinics and hospitals, and also by city (e.g., Lahore vs. other cities).
🛡️
Whether your health insurance covers the cost of the injections will significantly impact your out-of-pocket expenses.
For precise and up-to-date pricing specific to your needs, it is always best to **contact Suhail's Oculab directly**. We can provide detailed information regarding the cost of various injection types and discuss payment options.
Call for Pricing InformationWhile AMD is age-related and can't be entirely prevented, certain lifestyle choices and supplements can help reduce your risk or slow its progression.
🥗
💊
For individuals with **intermediate Dry AMD** or advanced AMD in one eye, the **AREDS2 (Age-Related Eye Disease Study 2) formula** supplements are recommended. These specific supplements have been scientifically proven to reduce the risk of progression to advanced AMD by about 25%.
The AREDS2 formula contains:
For accurate diagnosis, personalized treatment plans, and advanced care for Age-Related Macular Degeneration, trust Prof. Dr. Suhail Sarwar. With extensive experience in retinal diseases and the latest injection therapies, he is dedicated to preserving your vision.
Visit our main website: oculab.org or our partner site: eyehospitallahore.com.
A: The primary injections for Wet Age-Related Macular Degeneration (AMD) are called Anti-VEGF (Anti-Vascular Endothelial Growth Factor) injections. These medications, such as Lucentis (Ranibizumab), Eylea (Aflibercept), Avastin (Bevacizumab - off-label), and the newer Vabysmo (Faricimab), work by blocking a protein that causes abnormal blood vessels to grow and leak fluid under the macula.
A: For Wet AMD, Anti-VEGF injections are considered the gold standard and best treatment to stabilize vision and prevent further loss. For Dry AMD, there is currently no surgical treatment, but specific nutritional supplements (AREDS2 formula) can help slow its progression in intermediate stages. The 'best' treatment depends on the type and stage of AMD.
A: For Wet AMD, the drugs of choice are Anti-VEGF agents like Lucentis (Ranibizumab), Eylea (Aflibercept), and the newer Vabysmo (Faricimab). Avastin (Bevacizumab) is also widely used off-label. The choice among these often depends on individual patient factors, injection frequency needs, and local availability/cost.
A: Vabysmo (Faricimab) is one of the newer treatments for Wet AMD and Diabetic Macular Edema. It's a dual-pathway inhibitor that targets both VEGF-A and Ang-2, potentially leading to longer intervals between injections for some patients compared to previous treatments.
A: Anti-VEGF injections for Wet AMD have a high success rate in stabilizing vision and preventing further vision loss. Studies show that a significant percentage of patients maintain or improve their vision, with about one-third gaining substantial vision. It's highly effective in controlling the disease activity.
A: For intermediate Dry AMD, the AREDS2 (Age-Related Eye Disease Study 2) formula supplements are recommended. These contain specific doses of Vitamin C, Vitamin E, Zinc, Copper, Lutein, and Zeaxanthin, which have been shown to reduce the risk of progression to advanced AMD.
A: The number of injections for Wet AMD varies greatly by individual. Initially, a loading phase of 3 monthly injections is common. After that, treatment can be monthly, every 2-4 months, or on a 'treat-and-extend' basis, where intervals are gradually lengthened. Treatment is often ongoing for years to maintain vision.
A: The cost of macular degeneration injections in Pakistan can vary significantly based on the specific drug used (e.g., Lucentis, Eylea, Vabysmo, or Avastin), the clinic, and whether it's covered by insurance. It's best to consult directly with Suhail's Oculab for detailed pricing information.
A: While AMD is age-related, you can reduce your risk or slow its progression by: not smoking, eating a diet rich in leafy green vegetables and fish, maintaining a healthy weight, exercising regularly, managing blood pressure and cholesterol, and taking AREDS2 supplements if recommended by your doctor.
A: Vabysmo (Faricimab) is a very effective and promising new injection for Wet AMD. Its dual mechanism of action (targeting both VEGF-A and Ang-2) may allow for longer treatment intervals for some patients compared to other Anti-VEGF drugs. While it's a significant advancement, the 'best' injection can be subjective and depends on individual patient response and specific clinical circumstances, as determined by your retinal specialist.